论文部分内容阅读
包裹性胸膜炎是内科难治性疾病之一。近年来我们用尿激酶作胸腔内注射治疗本病,取得很好效果。现报告如下。 1 一般资料 我们将近年来收治的包裹性胸膜炎随机分成两组。治疗组22例在传统使用强的松口服及病因治疗的基础上加用尿激酶胸腔内注射。其中男15例,女7例,年龄16～45岁,平均28岁。病因:结核性19例,病毒性3例。部位:单侧包裹性胸膜炎20例,双侧包裹性胸膜炎2例。病程:3～10周。取同期21例包裹性胸膜炎作对照。
Encapsulated pleurisy is one of the medical refractory diseases. In recent years, we use urokinase for intrathoracic injection treatment of the disease, and achieved good results. The report is as follows. 1 General Information We will be treated in recent years wrapped pleurisy were randomly divided into two groups. In the treatment group, 22 cases were given intrathoracic injection of urokinase based on traditional oral administration of prednisone and etiological treatment. Including 15 males and 7 females, aged 16 to 45 years, mean 28 years. Etiology: tuberculosis in 19 cases, 3 cases of viral. Location: unilateral pleurisy in 20 cases, bilateral pleurisy in 2 cases. Course of disease: 3 to 10 weeks. Take the same period of 21 cases of paroxysmal pleurisy as a control.